{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-016201","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.694094+00:00","generated_at":"2026-06-25T04:36:31.307688+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Cumberland Pharmaceuticals announces retirement of EVP Leo Pavliv","bullets":["Leo Pavliv retired as EVP, Chief Development & Operations Officer effective May 31, 2022.","Pavliv entered into a consulting agreement to remain as Operations Advisor to the company.","His regulatory, product development and manufacturing duties have been assigned to other executives."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-016201","json":"https://secwatch.observer/filing/0001628280-22-016201.json","markdown":"https://secwatch.observer/filing/0001628280-22-016201.md","text":"https://secwatch.observer/filing/0001628280-22-016201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/0001628280-22-016201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/cpix-20220603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:36:31.307688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eb3cc7e1cd","claim":"Leo Pavliv retired as Executive Vice President, Chief Development & Operations Officer at CUMBERLAND PHARMACEUTICALS INC.","evidence_excerpt":"On May 31, 2022, Cumberland Pharmaceuticals Inc. (\"Cumberland\" or the \"Company\") announced the retirement of Leo Pavliv, Cumberland’s Executive Vice President, Chief Development & Operations Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/0001628280-22-016201-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President, Chief Development & Operations Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}